Literature DB >> 1017359

Chronobiology in the diagnosis and treatment of mesor-hypertension.

F C Bartter, C S Delea, W Baker, F Halberg, J K Lee.   

Abstract

An elevation of systolic and diastolic bloodpressure to values regarded as abnormal ones on the basis of conventional criteria was recognized by self-measurement. For both systolic and diastolic blood pressure, the overall means adjusted for rhythms, the so-called mesors, also were elevated in the light of their response to treatment: these mesors were found to be lowered with statistical significance when values during treatment were compared by an objective test with values measured before treatment. Individualized rhythmometry quantitatively characterizes a predictalbe portion of the variability in human blood pressure and tests for the statistical significance of changes in blood pressure as a function of the treatment and also as a function of the circadian timing of such treatment. The case report thus illustrates an individualized chronotherapy of systolic and diastolic mesor-hypertension, diagnosed retrospectively from the tested effect of hydrochlorothiazide. In the case reported, and perhaps routinely, computer-analyzed self-measurements can serve 1) to prescribe the right kind and amount with the right timing, for a given therapy, and 2) for diagnosis and prevention as well (Meyer et al.; Halberg et al.).

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1017359

Source DB:  PubMed          Journal:  Chronobiologia        ISSN: 0390-0037


  13 in total

1.  Transdisciplinary unifying implications of circadian findings in the 1950s.

Authors:  Franz Halberg; Germaine Cornélissen; George Katinas; Elena V Syutkina; Robert B Sothern; Rina Zaslavskaya; Francine Halberg; Yoshihiko Watanabe; Othild Schwartzkopff; Kuniaki Otsuka; Roberto Tarquini; Perfetto Frederico; Jarmila Siggelova
Journal:  J Circadian Rhythms       Date:  2003-10-29

2.  Why continued surveillance? Intermittent blood pressure and heart rate abnormality under treatment.

Authors:  G S Katinas; G Cornélissen; K Otsuka; E Haus; E E Bakken; F Halberg
Journal:  Biomed Pharmacother       Date:  2005-10       Impact factor: 6.529

3.  Changes in human blood pressure with season, age and solar cycles: a 26 year record.

Authors:  A Portela; G Northrup; F Halberg; G Cornélissen; H Wendt; J C Melby; E Haus
Journal:  Int J Biometeorol       Date:  1996-11       Impact factor: 3.787

4.  The chronotherapy of hypertension: or the benefit of taking blood pressure tablets at bedtime.

Authors:  Gervase Vernon
Journal:  Br J Gen Pract       Date:  2017-04       Impact factor: 5.386

5.  Chronobiology of catecholamine excretion in normal and diabetic men.

Authors:  G Del Rio; C Carani; A Baldini; P Marrama; L Della Casa
Journal:  J Endocrinol Invest       Date:  1990 Jul-Aug       Impact factor: 4.256

Review 6.  Clinical relevance of about-yearly changes in blood pressure and the environment.

Authors:  F Halberg; G Cornélissen; E Haus; G Northrup; A Portela; H Wendt; K Otsuka; Y Kumagai; Y Watanabe; R Zaslavskaya
Journal:  Int J Biometeorol       Date:  1996-11       Impact factor: 3.787

7.  CHRONOMICS AND GENETICS.

Authors:  F Halberg; G Cornélissen; G Katinas; J Dušek; P Homolka; Z Karpíšek; R P P Sonkowsky; O Schwartzkopff; B Fišer; J Siegelová
Journal:  Scr Med (Brno)       Date:  2007-10-01

8.  Daily variations in catecholamine excretion are not influenced by very low calorie diet in obese women.

Authors:  G Del Rio; A Velardo; G Zizzo; S Galetti; P Marrama; L Della Casa
Journal:  J Endocrinol Invest       Date:  1993 Jul-Aug       Impact factor: 4.256

9.  Rhythm characteristics of plasma renin, aldosterone and cortisol in five subtypes of mesor-hypertension.

Authors:  P Cugini; R Manconi; R Serdoz; A Mancini; T Meucci; D Scavo
Journal:  J Endocrinol Invest       Date:  1980 Apr-Jun       Impact factor: 4.256

Review 10.  Circadian clock-mediated regulation of blood pressure.

Authors:  Lauren G Douma; Michelle L Gumz
Journal:  Free Radic Biol Med       Date:  2017-12-02       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.